Pfizer CEO tests positive for COVID for the second time IG News

Pfizer CEO tests positive for COVID for the second time. Pfizer Inc. (PFE.N) Chief Executive Officer Albert Bourla said that on Saturday he had tested positive for COVID-19.

“I am feeling well and symptom-free,” Borla said in a statement.

Baurla, 60, had contracted COVID back in August and began a course of the company’s oral COVID-19 antiviral treatment, Paxlovid.

Paxlovid is an antiviral medicine used to treat high-risk people, such as older patients.

Borla has received four doses of the COVID vaccine developed by Pfizer and its German partner BioNTech (22UAy.DE).

The chief executive said he had not yet received the new bivalent booster.

Read more: 22 more dengue cases reported in Islamabad

Developed by Moderna and the team from Pfizer and BioNTech, the new so-called bivalent shots aim to tackle the BA.5 and BA.4 omicron subvariants, which make up 84.8% and 1.8%, respectively, of all circulating variants in the United States. State based on the latest figures.

“I don’t have the new bivalent booster yet, because I was following CDC guidelines to wait three months for my last COVID case, which was back in mid-August,” said Borla. “

In August, the FDA authorized updated booster shots from Pfizer and Moderna that target the major BA.4 and BA.5 Omicron subvariants.

A federal health agency said this week that more than 25 million doses of so-called binaural shots had been dispatched. This included most of the Pfizer/BioNTech vaccines, as production of the modern vaccine accelerated.


Most Popular